- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07592624
Evaluation of an Instructional Video About Medication Management During Admission and Medication Adherence for Kidney Transplantation and in the Outpatient Clinic in a Dutch University Hospital. (MediT)
The goal of this RCT is to evaluate the effect of the instructional video on improving patient compliance and reducing medication errors. The study will include adult kidney transplant recipients (18 years or older) at Erasmus MC who have undergone a kidney transplantation starting January 2026.
The main questions it aims to answer:
The primary aim of this study is to assess whether our developed video instruction, compared with the traditional verbal instruction, both of which are given shortly before training during admission, reduces the number of medication errors in kidney transplant patients.
The study will also examine the correlation between patient characteristics (such as age, comorbidities, and language proficiency) and medication errors. Additionally, patient-reported medication errors will be measured through a questionnaire completed during follow-up visits at the outpatient clinic, which is part of standard care.
The instructional video will be evaluated by a short questionnaire.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Myrthe van der Zanden, MSc, Drs
- Telefoonnummer: +31650094899
- E-mail: m.vanderzanden@erasmusmc.nl
Studie Locaties
-
-
-
Rotterdam, Nederland, 3015GD
- Erasmus Medical Center
-
Contact:
- Myrthe van der Zanden, MSc, Drs.
- Telefoonnummer: +31650094899
- E-mail: m.vanderzanden@erasmusmc.nl
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- The patient is able to take the medication independently or with the help of someone else (professionals not included).
- After admission, the patient is discharged to their own home or home of friend/relative.
- The patient had a follow up at the outpatient clinic in the Erasmus Medical Center for at least one year after transplantation.
- The patient is able to read the medication list or an illiteracy-friendly medication list.
Exclusion Criteria:
- Patients under 18 years of age
- Patients who got discharged with a medication dispenser
- Refusal to participate in the study.
- Cognitive impairments that hinder participation.
- Patients and/or family who can not understand (language barrier) the instructional video.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Geen tussenkomst: Verbal instruction
Patients receive the verbal instruction about medication training from the nurses.
|
|
|
Experimenteel: Video instruction
Patients receive the instruction video about medication training from the nurses.
|
Self developed instructional video for a Dutch university hospital, for Dutch kidney transplant patients.
Instructional video is about medication administration during admission.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Incidence and type of medication errors during admission
Tijdsspanne: During admission
|
The primary outcome of this study will be the incidence (number of medication errors) and type of medication errors ( 1)Medication preparation omitted, 2) Incorrect dosage, 3) Incorrect administration at the scheduled time, 4), Medication discontinued inappropriately, 5)Error not documented by the nurse) during admission, evaluated through direct observation by healthcare providers.
These errors will be documented and reported via patient portals by nurses.
|
During admission
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Patient characteristics
Tijdsspanne: During admission
|
Age (in years), gender (male/female/nonbinair), country of origin, language proficiency, number of previous organ transplantations, donor type of the kidney transplant (DCD, DBD, Living), and renal replacement therapy (HD/PD/Pre-emptive).
|
During admission
|
|
Evaluation of the instructional video
Tijdsspanne: At the end of admission
|
Structured questionnaire with the following questions:
|
At the end of admission
|
|
BAASIS
Tijdsspanne: During the first year follow up at the out patient clinic after kidney transplantation in the Erasmus MC
|
Participants will complete a patient-reported questionnaire (BAASIS) every three months during the first year after transplantation. The questionnaire consists of five yes/no questions related to medication errors occurring in the home setting. The questions will ask whether the participant has:
The goal is to evaluate whether there is a reduction in home-reported medication errors for those who receive a different medication management training method in the hospital. |
During the first year follow up at the out patient clinic after kidney transplantation in the Erasmus MC
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie stoel: Jacqueline van de Wetering, MD, Dr., Erasmus Medical Center
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 14372
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .